Genomic Evolution of Breast Cancer Metastasis and Relapse - ScienceDirect

$ 33.99

5
(573)
In stock
Description

Expression of SOX4 significantly predicts the risk of lymph node metastasis for patients with early-stage esophageal squamous cell carcinoma - Laboratory Investigation

A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard - Modern Pathology

JCI - Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study - The Lancet Oncology

Genomic Evolution of Breast Cancer Metastasis and Relapse - ScienceDirect

Genomic Evolution of Breast Cancer Metastasis and Relapse - ScienceDirect

PDF) Personalised Pathway Analysis Reveals Association between DNA Repair Pathway Dysregulation and Chromosomal Instability in Sporadic Breast Cancer

Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models? - Computational and Structural Biotechnology Journal

HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity - Modern Pathology

Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma - ScienceDirect

IJMS, Free Full-Text